Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 40, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 April 2026 - 12:50

Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 40, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/caelyx-pegylated-liposomal

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters